56 related articles for article (PubMed ID: 2046447)
1. [Spurious hypoglycemia and chronic myeloid leukemia].
de Sas M; Fernández G; Novoa F
Med Clin (Barc); 1991 Mar; 96(9):356. PubMed ID: 2046447
[No Abstract] [Full Text] [Related]
2. A two-color BCR-ABL probe that greatly reduces the false positive and false negative rates for fluorescence in situ hybridization in chronic myeloid leukemia.
Grand FH; Chase A; Iqbal S; Nguyen DX; Lewis JL; Marley SB; Davidson RJ; Goldman JM; Gordon MY
Genes Chromosomes Cancer; 1998 Oct; 23(2):109-15. PubMed ID: 9739013
[TBL] [Abstract][Full Text] [Related]
3. Pseudohypoglycemia in chronic leukemia.
Assaad SN; Vassilopoulou-Sellin R; Samaan NA
Tex Med; 1988 Jul; 84(7):36-7. PubMed ID: 3166239
[No Abstract] [Full Text] [Related]
4. [In vitro glucose consumption in severe hyperleukocytosis. A cause of factitious hypoglycemia].
Canivet B; Squara P; Elbaze P; Gratecos N; Cassuto JP; Dujardin P; Freychet P
Pathol Biol (Paris); 1982 Dec; 30(10):843-6. PubMed ID: 6760061
[TBL] [Abstract][Full Text] [Related]
5. [The usefulness of the bcr/abl rearrangement in the diagnosis and evolution of chronic myeloid leukemia].
González FA; Villegas A; Ferro MT; San Román C; Sáez I; López M; del Potro E; Alvarez A; Martínez R; Díaz Madiavilla J
Med Clin (Barc); 1993 Oct; 101(14):521-4. PubMed ID: 8231395
[TBL] [Abstract][Full Text] [Related]
6. Circulating bcr-abl-specific CD8+ T cells in chronic myeloid leukemia patients and healthy subjects.
Butt NM; Rojas JM; Wang L; Christmas SE; Abu-Eisha HM; Clark RE
Haematologica; 2005 Oct; 90(10):1315-23. PubMed ID: 16219567
[TBL] [Abstract][Full Text] [Related]
7. No evidence for persistence of BCR-ABL-positive cells in patients in molecular remission after conventional allogenic transplantation for chronic myeloid leukemia.
Deininger M; Lehmann T; Krahl R; Hennig E; Müller C; Niederwieser D
Blood; 2000 Jul; 96(2):779-80. PubMed ID: 10950517
[No Abstract] [Full Text] [Related]
8. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].
Akhlynina TV; Gerasimova LP; Sarkisian GP; Borovkova TV; Dukhovenskaia EA; Manakova TE; Naĭdenova NM; Timofeev AM; Grineva NI
Tsitologiia; 2007; 49(10):889-900. PubMed ID: 18074781
[TBL] [Abstract][Full Text] [Related]
9. [The prognostic significance of the differential blood count in patients with chronic myeloid leukemia].
Zankovich R; Schilling H; Thiele J; Kvasnicka HM; Diehl V
Med Klin (Munich); 1989 Aug; 84(8):373-7. PubMed ID: 2796866
[TBL] [Abstract][Full Text] [Related]
10. Blood bioamines, cortisol and aminoacid levels in leukemic patients.
Singh JN; Chansouria JP; Singh VP; Udupa KN
Indian J Cancer; 1989 Dec; 26(4):222-6. PubMed ID: 2636208
[TBL] [Abstract][Full Text] [Related]
11. Correlation between trough imatinib plasma concentration and clinical response in chronic myeloid leukemia.
Mahon FX; Molimard M
Leuk Res; 2009 Aug; 33(8):1147-8; author reply 1149-50. PubMed ID: 19395027
[No Abstract] [Full Text] [Related]
12. High-resolution melt curve analysis: initial screening for mutations in BCR-ABL kinase domain.
Poláková KM; Lopotová T; Klamová H; Moravcová J
Leuk Res; 2008 Aug; 32(8):1236-43. PubMed ID: 18308387
[TBL] [Abstract][Full Text] [Related]
13. Interferon-alpha-treated patients with chronic myelogenous leukemia show BCR/ABL-positive peripheral blood progenitor cells surviving long-term culture.
Schultheis B; Heissig B; Pasternak G; Hörner S; Hehlmann R
Folia Biol (Praha); 2000; 46(6):251-5. PubMed ID: 11140858
[TBL] [Abstract][Full Text] [Related]
14. Relationship of the BCR gene breakpoint and the type of BCR/ABL transcript to clinical course, prognostic indexes and survival in patients with chronic myeloid leukemia.
Prejzner W
Med Sci Monit; 2002 May; 8(5):BR193-7. PubMed ID: 12011769
[TBL] [Abstract][Full Text] [Related]
15. Erythroid blast crisis of chronic myeloid leukemia.
Chemlal K; Grange MJ; Yeni P
Haematologica; 1996; 81(4):378. PubMed ID: 8870386
[No Abstract] [Full Text] [Related]
16. Myeloid mixed chimerism is associated with relapse in bcr-abl positive patients after unmanipulated allogeneic bone marrow transplantation for chronic myelogenous leukemia.
Román J; Serrano J; Jiménez A; Castillejo JA; Reina ML; González MG; Rodríguez MC; García I; Sánchez J; Maldonado J; Torres A
Haematologica; 2000 Feb; 85(2):173-80. PubMed ID: 10681725
[TBL] [Abstract][Full Text] [Related]
17. [The phenomenon of selective hyposegmentation of eosinophilic granulocytic nuclei].
Ronin VS
Lab Delo; 1989; (6):26-7. PubMed ID: 2474697
[TBL] [Abstract][Full Text] [Related]
18. Whole blood suspension culture method for chromosome examination of a patient with Ph-positive chronic myeloid leukaemia.
Selypes A; László A; Virág I
Haematologia (Budap); 1990; 23(1):57-60. PubMed ID: 2397924
[No Abstract] [Full Text] [Related]
19. Chronic myeloid leukemia.
Nash I
N Engl J Med; 1999 Sep; 341(10):765. PubMed ID: 10475801
[No Abstract] [Full Text] [Related]
20. Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia.
Mittal P; Saliba RM; Giralt SA; Shahjahan M; Cohen AI; Karandish S; Onida F; Beran M; Champlin RE; de Lima M
Bone Marrow Transplant; 2004 May; 33(10):1005-9. PubMed ID: 15048141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
